MedPath

Sodium Chloride

0.9% Sodium Chloride Injection, USP in FLEBOFLEX and FLEBOFLEX LUER Plastic Container

Approved
Approval ID

eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 31, 2023

Manufacturers
FDA

LABORATORIOS GRIFOLS SA

DUNS: 461842294

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76297-001
Application NumberANDA207956
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 19, 2022
FDA Product Classification

INGREDIENTS (2)

Sodium ChlorideActive
Quantity: 9 g in 1000 mL
Code: 451W47IQ8X
Classification: ACTIB
WaterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Chloride - FDA Drug Approval Details